The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved leniolisib phosphate (Joenja) as the first treatment for activated...
Read moreDetailsThe Medicines and Healthcare products Regulatory Agency (MHRA) has approved fruquintinib, known as Fruzaqla, for treating adults with metastatic colorectal...
Read moreDetailsThe Medicines and Healthcare products Regulatory Agency (MHRA) has unveiled an ambitious new strategy to transform the way it communicates...
Read moreDetailsOn September 12, 2024, Prime Minister Keir Starmer delivered a significant speech on the National Health Service (NHS) at the...
Read moreDetailsThe Prime Minister pledged the most extensive reform of the NHS since its inception, following the release of a critical...
Read moreDetailsThe Competition and Markets Authority (CMA) has successfully defended its decision in a significant drug market-sharing appeal, reinforcing its role...
Read moreDetailsThe UK has taken another decisive step in the fight against COVID-19. On 3 September 2024, the Medicines and Healthcare...
Read moreDetailsAt the heart of London, a wave of discontent is sweeping through Guys’ and St Thomas’ Hospital as nurses intensify...
Read moreDetailsThe struggle to keep NHS jobs in-house intensifies as Colchester Hospital support staff prepare for a five-day strike starting on...
Read moreDetailsAs the school gates swing open, parents and teachers alike find themselves in a whirlwind of preparation. Among the chaos...
Read moreDetailsReporting on the Official Record.
THX News delivers clarity through source-led reporting from primary documents, government releases, public data, and institutional records. Our commitment is to foster an informed global community through fact-driven reporting you can trust.
© 2020–2026 THX News LLC. All Rights Reserved.
© 2020–2026 THX News LLC. All Rights Reserved.